H-group (homology)
208.1 Trimeric LpxA-like enzymes
Ligands and drugs
4,446
Member domains
1,162
with ligand contacts (≤ 4 Å)
26.1% of members
1,031
with DrugDomain annotations
23.2% of members
726
with a DrugBank compound
16.3% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 208.1 belongs to X-group 208 Single-stranded left-handed beta-helix, which binds 8.7 ligand superclasses per 20 proteins, broader than 71% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01992 | COA | Coenzyme A | 105 |
| DB00151 | CYS | Cysteine | 45 |
| DB00131 | AMP | Adenosine phosphate | 28 |
| DB05869 | 9X7 | Ethyl pyruvate | 20 |
| DB00119 | PYR | Pyruvic acid | 16 |
| DB04551 | FBP | beta-D-fructofuranose 1,6-bisphosphate | 15 |
| DB03103 | TYD | Thymidine-5'- Diphosphate | 13 |
| DB03912 | PNS | D-pantetheine 4'-phosphate | 12 |
| DB04348 | TCH | Taurocholic acid | 12 |
| DB03462 | TDR | Thymine | 11 |
| DB03397 | UD1 | Uridine-Diphosphate-N-Acetylglucosamine | 10 |
| DB03556 | PE5 | 2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400 | 10 |
| DB00133 | SER | Serine | 9 |
| DB03134 | NPI | L-2-aminopimelic acid | 9 |
| DB03345 | BME | Mercaptoethanol | 9 |
| DB03796 | PLM | Palmitic Acid | 9 |
| DB01861 | UPG | Uridine diphosphate glucose | 8 |
| DB01669 | VIR | Virginiamycin M1 | 6 |
| DB02767 | FTT | (R)-3-hydroxytetradecanoic acid | 6 |
| DB03699 | SCA | Succinyl-Coenzyme A | 6 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 154 |
| ZNmetal | ZINC ION | 112 |
| MGmetal | MAGNESIUM ION | 110 |
| COA | COENZYME A | 109 |
| ACO | ACETYL COENZYME *A | 76 |
| NAmetal | SODIUM ION | 59 |
| CYS | CYSTEINE | 47 |
| VFE | 2-[2-(2-chlorophenyl)sulfanylethanoyl-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]amino]-N-methyl-ethanamide | 34 |
| VFN | ~{N}-[(5-azanyl-1,3,4-oxadiazol-2-yl)methyl]-2-(2-chlorophenyl)sulfanyl-~{N}-[(4-cyanophenyl)methyl]ethanamide | 33 |
| VFT | 2-(2-chlorophenyl)sulfanyl-~{N}-[(4-cyanophenyl)methyl]-~{N}-(1~{H}-imidazol-4-ylmethyl)ethanamide | 30 |
| VFZ | ~{N}-[(5-azanyl-1,3,4-oxadiazol-2-yl)methyl]-2-(2-chlorophenyl)sulfanyl-~{N}-[(6-oxidanylidene-1~{H}-pyridin-3-yl)methyl]ethanamide | 30 |
| AMP | ADENOSINE MONOPHOSPHATE | 28 |
| CAmetal | CALCIUM ION | 25 |
| O3V | 3-hydroxy-7,7-dimethyl-2-phenyl-4-(thiophen-2-yl)-2,6,7,8-tetrahydro-5H-pyrazolo[3,4-b]quinolin-5-one | 24 |
| 9X7 | ethyl 2-oxopropanoate | 20 |
| COmetal | COBALT (II) ION | 17 |
| PYR | PYRUVIC ACID | 16 |
| COO | CROTONYL COENZYME A | 14 |
| FBP | 1,6-di-O-phosphono-beta-D-fructofuranose | 14 |
| UD1 | URIDINE-DIPHOSPHATE-N-ACETYLGLUCOSAMINE | 14 |